Poolbeg Pharma PLC (LON:POLB – Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 2.25 ($0.03) and last traded at GBX 2.40 ($0.03), with a volume of 535255 shares traded. The stock had previously closed at GBX 2.43 ($0.03).
Wall Street Analysts Forecast Growth
Separately, Shore Capital reiterated a “house stock” rating on shares of Poolbeg Pharma in a research note on Thursday, January 2nd.
View Our Latest Stock Report on Poolbeg Pharma
Poolbeg Pharma Price Performance
About Poolbeg Pharma
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. Poolbeg comprises a strong and growing portfolio of development assets.
Read More
- Five stocks we like better than Poolbeg Pharma
- Technology Stocks Explained: Here’s What to Know About Tech
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- How to Calculate Return on Investment (ROI)
- Are Tariffs Threatening Disney’s Comeback Story?
- About the Markup Calculator
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Poolbeg Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Poolbeg Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
